Is micronucleus induction by aneugens an early event leading to mutagenesis?

Mutagenesis

Volumn 9, Issue 5, 1994, Pages 411-416

  Stopper, Helga ^a   Eckert, Inge ^a   Schiffmann, Dietmar ^b   Spencer, Diane L ^c   Caspary, William J ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEMECOLCINE; DIETHYLSTILBESTROL; GRISEOFULVIN; TRIFLURIDINE; VINBLASTINE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CENTROMERE; CONTROLLED STUDY; LEUKEMIA L 5178 Y; MICRONUCLEUS; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; STAINING;

ANIMAL; COMPARATIVE STUDY; DEMECOLCINE; DIETHYLSTILBESTROL; DRUG RESISTANCE; GRISEOFULVIN; KINETOCHORES; LEUKEMIA L5178; MICE; MICRONUCLEI; MICRONUCLEUS TESTS; MUTAGENESIS; MUTAGENS; SUPPORT, NON-U.S. GOV'T; THYMIDINE KINASE; TRIFLURIDINE; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0027956970     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/9.5.411     Document Type: Article

References (39)

1. Amacher, D.E., Paillet, S.C., Turner, G.N., Ray, V.A. and Salzburg, D.S. (1980) Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells: n. Test validation and interpretation. Mutat. Res., 72, 447–474.
2. Barrett, J.C., Wong, A. and McLachlan, J.A. (1981) Diethylstilbestrol induces neoplastic transformation without measurable gene mutation at two loci. Science, 212, 1402–1404.
3. Barrett, J.C., McLachlan, J.A. and Elmore, E. (1983) Inability of diethylstilbestrol to induce 6-thioguanine-resistant mutants and to inhibit metabolic cooperation of V79 Chinese hamster cells. Mutat. Res., 107, 427–432.
4. Blazak, W., Stewart, B., Galperin, I., Allen, K., Rudd, C., Mitchell, A. and Caspary, W. (1986a) Chromosome analysis of trifluorothymidine-resistant L5178Y mouse lymphoma cell colonies. Environ. Mutagen., 8, 229–240.
5. Blazak, W., Stewart, B., Galperin, I., Allen, K., Rudd, C., Mitchell, A. and Caspary, W. (1986b) Stable dicentric chromosomes induced by chemical mutagens in L5178Y mouse lymphoma cells. Mutat. Res., 173, 263–266.
6. Blazak, W.F., Los, F.J., Rudd, C.J. and Caspary, WJ. (1989) Chromosome analysis of small and large L5178Y mouse lymphoma cell colonies. Comparison of trifluorothymidine-resistant and unselected cell colonies from mutagen-treated and control cultures. Mutat. Res., 224, 197–208.
7. Caspary, W. and Myhr, B. (1986) Mutagenicity of methylisocyanate and its reaction products to cultured mammalian cells. Mutat. Res., 174, 285–293
8. Clive, D. (1985) Mutagenicity in drug development: interpretation and significance of test results. Regul. Toxicol. Pharmacol., 5, 79–100.
9. Clive, D., Flamm, W.G., Machesko, M.R. and Bercheim, N.J. (1972) Mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutat. Res., 16, 77–87.
10. Clive, D., Johnson, K., Spector, J., Batson, A. and Brown, M.M. (1979) Validation and characterization of the L5178Y/tk mouse lymphoma mutagen assay system. Mutat. Res., 59, 61–108.
11. Clive, D., Glover, P., Applegate, M. and Hozier, J. (1990) Molecular aspects of chemical mutagenesis in L5178Y/tk+/− mouse lymphoma cells. Mutagenesis, 5, 191–187.
12. −/− mutants. Mutat. Res., 253, 73–82.
13. Drevon, C., Piccoli, C. and Montesano, R. (1981) Mutagenicity assays of estrogenic hormones in mammalian cells. Mutat. Res., 89, 83–90.
14. Evans, H.H., Mencl, J., Homg, M.-F., Ricanati, M., Sanchez, C. and Hozier, J. (1986) Locus specificity in the mutability of L5178Y mouse lymphoma cells: the role of multilocus lesions. Proc. Natl Acad. Sci. USA, 83, 4379–4383.
15. Fenech, M. (1993) The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat. Res., 285, 35–44.
16. Fritzenschaf, H., Kohlpoth, M., Rusche, B. and Schiffinann, D. (1993) Testing of known carcinogens and noncareinogens in the Syrian hamster embryo (SHE) micronucleus test in vitro: correlation with in vivo micronucleus formation and cell transformation. Mutat. Res., 319, 47–53.
17. Gudi, R., Xu, Y. and Thilager, A. (1992) Assessment of the in vivo aneuploidy/micronucleus assay in mouse bone marrow cells with 16 chemicals. Environ. Mol. Mutagen., 20, 106–116.
18. −/− mutants early in their clonal history. Mutat. Res., 147, 237–242.
19. −/− mutants. Mutat. Res., 214, 195–199.
20. Hozier, J., Scalzi, J., Sawyer, J., Carley, N., Applegate, M., Clive, D. and Moore, M. (1991) Localization of the mouse thymidine kinase gene to the distal portion of chromosome 11. Genomics, 10, 827–832.
21. −/− mutants. Mutat. Res., 286, 299–307.
22. Matsuoka, A., Yamasaki, N., Suzuki, T., Hayashi, N. and Sofuni, T. (1993) Evaluation of the micronucleus test using a Chinese hamster cell line as an alternative to the conventional in vitro chromosomal aberration test. Mutat. Res., 272, 223–236.
23. McGregor, D.B., Brown, A.G., Cattanach, P., Shepherd, W., Riach, C., Daston, D.S. and Caspary, W.J. (1989) TFT and 6TG resistance of mouse lymphoma cells to analogs of azacytidine. Carcinogenesis, 10, 2003–2008.
24. McGregor, D., Brown, A., Howgate, S., McBride, D., Riach, C. and Caspary, W. (1991) Responses of the L5178Y mouse lymphoma forward mutation assay: V. 27 coded chemicals. Environ. Mol. Mutagen., 17, 196–219.
25. McGregor, D., Riach, C. and Caspary, W.J. (1994) Comparison of the mutagenic response of L5178Y cells at the tk and hprt loci. Environ. Mol. Mutagen., submitted.
26. Mitchell, A., Rudd, C., Myhr, B. and Caspary, W. (1988) Evaluation of the mouse L5178Y lymphoma system as an indicator of the mutagenic activity of chemicals: results of assays of sixty-three coded chemicals tested at SRI International. Environ. Mol. Mutagen., 12 (Suppl. 13), 37–102.
27. +/− mouse lymphoma cells. Mutat. Res., 151, 161–174.
28. Moore, M.M., Harrington-Brock, K., Doerr, C. and Dearfield, K.L. (1989) Differentia] mutant quantitation at the mouse lymphoma tk and CHO hprt loci. Mutagenesis, 4, 394–403.
29. Myhr, B., Bowers, L. and Caspary, W. (1985) Assays for the induction of gene mutation at the thymidine kinase locus in L5178Y mouse lymphoma cells in culture. In Ashby, J., de Senes, F.J. et al. (eds), Progress in Mutation Research. Elsevier, Amsterdam, pp. 555–568.
30. Myhr, B., Mitchell, A. and Caspary, W.J. (1988) Evaluation of the mouse L5178Y lymphoma system as an indicator of the mutagenic activity of chemicals: results of assays of sixty-three coded chemicals tested at Litton Bionetics, Inc., Environ. Mol. Mutagen., 12 (Suppl. 13), 103–194.
31. Myhr, B., McGregor, D., Bowers, L., Riach, C., Brown, A., Edwards, I., McBride, D., Martin, R. and Caspary, W. (1990) L5178Y mouse lymphoma cell mutation assay results with 41 compounds. Environ. Mol. Mutagen., 16 (Suppl. 18), 138–167.
32. Oberly, T.J., Bewsey, B.J. and Probst, G.S. (1984) An evaluation of the L5178Y mouse lymphoma forward mutation assay using 42 chemicals. Mutat. Res., 125, 291–306.
33. Rudd, C., Daston, D. and Caspary, W. (1990) Spontaneous mutation rates in mammalian cells: effect of differential growth rates and phenotypic lag. Genetics, 126, 435–442.
34. Schiffmann, D. and DeBoni, U. (1991) Dislocation of chromatin elements in prophase induced by diethylstilbestrol: a novel mechanism by which micronuclei can arise. Mutat. Res., 246, 113–122.
35. Spencer, D.L. and Caspary, W.J. (1994) In situ and suspension protocols of mutation at the tk locus in L5178Y mouse cells: dose response and colony size distribution, submitted.
36. Spencer, D.L., Hines, K.C. and Caspary, W.J. (1994) An in situ protocol for measuring the expression of chemically-induced mutations in mammalian cells. Mutat. Res., 312, 85–97.
37. Stopper, H., Körber, C., Schiffmann, D. and Caspary, W.J. (1993a) Cell cycle dependent micronucleus formation and mitotic disturbances in mammalian cells treated with 5-azacytidine. Mutat. Res., 300, 165–177.
38. Stopper, H., Körber, C., Spencer, D.L., Kirchner, S., Caspary, W.J and Schiffmann, D. (1993b) An investigation of micronucleus and mutation induction by oxazepam in mammalian cells. Mutagenesis, 8, 449–455.
39. Yandell, D.W., Dryja, T.P. and Litle, J.B. (1986) Somatic mutations at a heterozygous autosomal locus in human cells occur more frequently by allele loss than by intragnic structural alteration, Somatic Cell Mol. Genet., 12, 255–263.